People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HistoSonics, Inc. | — | Other Health Care | Series D+ | $308.2M | $1.0B | 2018 |
Dan Bulver at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dan Bulver on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerry Brunk | 1 | 5 |
| Linda Tufts | 1 | 5 |
| Jon Freeman | 1 | 5 |
| JAMES ADOX | 1 | 5 |
| V. Kadir Kadhiresan | 1 | 5 |
| Michael Blue | 1 | 4 |
| Kadir Kadhiresan | 1 | 4 |
| Andrew Von Eschenbach | 1 | 3 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Wen Chen | 1 | 3 |
| Jim Adox | 1 | 2 |
| Fred Lee | 1 | 2 |
| Richard Eric Bosler | 1 | 2 |
| Tom Tefft | 1 | 2 |
| Akhil Tripathi | 1 | 2 |
| Robert Morff | 1 | 2 |
| Mike Daniel | 1 | 1 |
| Josh Stopek | 1 | 1 |
| Tom Christine Tefft | 1 | 1 |
| Josh Christine Stopek | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.